Chapter 5 : Melanin: Structure, Function, and Biosynthesis in

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Melanin: Structure, Function, and Biosynthesis in , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816858/9781555815011_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555816858/9781555815011_Chap05-2.gif


There is an extensive body of evidence from several laboratories that establishes a role for melanization in virulence, providing a fascinating example of how a microorganism can utilize a ubiquitous pigment to undermine host defense mechanisms. Melanin-deficient mutant strains generated by UV-irradiation are avirulent in murine models of cryptococcal infection. The majority of melanin is produced by Lac1, although a second laccase enzyme, Lac2, adjacent to LAC1 in the genome exists. Various microscopy techniques were used to develop the melanin model, including atomic force and scanning electron microscopy to examine the surface structure of melanin, transmission electron microscopy (TEM) to study cross sections of melanin, and nuclear magnetic resonance (NMR) cryoporometry to investigate the porosity of melanin. In the environment, melanin is thought to protect from various stresses including enzymatic degradation, radiation (UV, solar, gamma), and heavy metals (silver nitrate) while providing thermotolerance and structural integrity to withstand osmotic challenges. Melanin-binding drugs may be useful as therapeutics against infection. In fact, administration of melanin-binding monoclonal antibodies (MAbs) prolongs the survival of mice in a lethal intravenous infection model. In this study, the fungal burdens of collected brains and lungs of infected mice were taken 7 days after infection, and mice administered MAbs to melanin had significantly lower fungal burdens than control mice administered irrelevant immunoglobulin. Early studies that linked melanin to virulence used classical genetic techniques to generate mutants through nonspecific mutagenesis to identify yeast cells deficient in melanin production.

Citation: Trofa D, Casadevall A, Nosanchuk J. 2011. Melanin: Structure, Function, and Biosynthesis in , p 55-66. In Heitman J, Kozel T, Kwon-Chung K, Perfect J, Casadevall A (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555816858.ch5

Key Concept Ranking

Tumor Necrosis Factor alpha
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

Mason-Roper model for melanogenesis of beginning with L-dopa as the phenolic substrate.

Citation: Trofa D, Casadevall A, Nosanchuk J. 2011. Melanin: Structure, Function, and Biosynthesis in , p 55-66. In Heitman J, Kozel T, Kwon-Chung K, Perfect J, Casadevall A (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555816858.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

(A) Scanning and (B) transmission electron micrographs of melanin ghosts. Scale bars, 1 μm. Transmission electron micrograph courtesy of H. Eisenman.

Citation: Trofa D, Casadevall A, Nosanchuk J. 2011. Melanin: Structure, Function, and Biosynthesis in , p 55-66. In Heitman J, Kozel T, Kwon-Chung K, Perfect J, Casadevall A (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555816858.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3

Cross-sectional depiction of the microstructure of a melaninzed cell wall. Multiple layers of melanin granules form into a dense layer in the cell wall. The packing of the granules allows for the acquisition of nutrients, such as sugars and amino acids. However, the melanin-binding antibody can block the passage of nutrients. The packing further inhibits the passage of certain large antifungal compounds, such as polyenes and pneumocandins. (Adapted from reference .)

Citation: Trofa D, Casadevall A, Nosanchuk J. 2011. Melanin: Structure, Function, and Biosynthesis in , p 55-66. In Heitman J, Kozel T, Kwon-Chung K, Perfect J, Casadevall A (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555816858.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint


1. al-Doory, Y. 1971. The ultrastructure of Cryptococcus neoformans. Sabouraudia 9:115118.
2. Alspaugh, J. A.,, J.R. Perfect, and, J. Heitman. 1997. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev. 11:32063217.
3. Alspaugh, J. A.,, R. Pukkila-Worley,, T. Harashima,, L. M. Cavallo,, D. Funnell,, G. M. Cox,, J. R. Perfect,, J. W. Kronstad,, and J. Heitman. 2002. Adenylyl cyclase functions downstream of the Galpha protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot. Cell 1:7584.
4. Avramidis, N.,, A. Kourounakis,, L. Hadjipetrou,, and V. Senchuk. 1998. Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease. Arzneimittelforschung 48:764771.
5. Banks, I. R.,, C.A. Specht,, M.J. Donlin,, K. J Gerik,, S. M. Levitz,, and J. K. Lodge. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:19021912.
6. Blasi, E.,, R. Barluzzi,, R. Mazzolla,, B. Tancini,, S. Saleppico,, M. Puliti,, L. Pitzurra,, and F. Bistoni. 1995. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J. Neuroimmunol. 58:111116.
7. Broekhuyse, R. M., E. D. Kuhlman, and, H. J. Winkens. 1992. Experimental autoimmune anterior uveitis (EAAU). II. Dose-dependent induction and adoptive transfer using a melanin-bound antigen of the retinal pigment epithelium. Exp. Eye Res. 55:401411.
8. Broekhuyse, R. M., E. D. Kuhlmann, and, R. J. Winkens. 1993. Experimental autoimmune anterior uveitis (EAAU): induction by melanin antigen and suppression by various treatments. Pigment Cell Res. 6:16.
9. Bull, A. T. 1970. Inhibition of polysaccharases by melanin: enzyme inhibition in relation to mycolysis. Arch. Biochem. Biophys. 137:345356.
10. Bull, A. T. 1970. Kinetics of cellulase inactivation by melanin. Enzymologia. 39:333347.
11. Bunting, L. A., J. B. Neilson, and, G. S. Bulmer. 1979. Cryptococcus neoformans: gastronomic delight of a soil ameba. Sabouraudia. 17:225232.
12. Butler, M. J., and, A. W. Day. 1998. Fungal melanins: a review. Can.. J. Microbiol. 44:11151136.
13. Casadevall, A., and, J. R. Perfect. 1998. Cryptococcus neoformans. ASM Press, Washington, DC.
14. Casadevall, A., A. L. Rosas, and, J. D. Nosanchuk. 2000. Melanin and virulence in Cryptococcus neoformans. Curr. Opin. Microbiol. 3:354358.
15. Chang, Y. C., L. A. Penoyer, and, K. J. Kwon-Chung. 2001. The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence. Proc. Natl. Acad. Sci. USA 98:32583263.
16. Chang, Y. C.,, B.L. Wickes,, G. F. Miller, L. A. Penoyer,, and K. J. Kwon-Chung. 2000. Cryptococcus neoformans STE12alpha regulates virulence but is not essential for mating. J. Exp. Med. 191:871882.
17. Chaskes, S., and, R. L. Tyndall. 1978. Pigment production by Cryptococcus neoformans and other Cryptococcus species from aminophenols and diaminobenzenes. J. Clin. Microbiol. 7:146152.
18. Chaskes, S., and, R. L. Tyndall. 1975. Pigment production by Cryptococcus neoformans from para- and orthodiphenols: effect of the nitrogen source. J. Clin. Microbiol. 1:509514.
19. Currie, B. P.,, L.F. Freundlich, and, A. Casadevall. 1994. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J. Clin. Microbiol. 32:11881192.
20. Dadachova, E.,, R. A. Bryan,, R. C. Howell,, A. D. Schweitzer,, P. Aisen,, J. D. Nosanchuk,, and A. Casadevall. 2008. The radioprotective properties of fungal melanin are a function of its chemical composition, stable radical presence and spatial arrangement. Pigment Cell Melanoma Res. 21:192199.
21. Diamond, R. D.,, J.E. May,, M. A. Kane, M. M. Frank,, and J. E. Bennett. 1974. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J. Immunol. 112:22602270.
22. d’Ischia, M., and, G. Prota. 1997. Biosynthesis, structure, and function of neuromelanin and its relation to Parkinson’s disease: a critical update. Pigment Cell Res. 10:370376.
23. Doering, T. L.,, J. D. Nosanchuk,, W. K. Roberts,, and A. Casadevall. 1999. Melanin as a potential cryptococcal defence against microbicidal proteins. Med. Mycol. 37:175181.
24. D’Souza, C. A.,, J. A. Alspaugh,, C. Yue,, T. Harashima,, G. M. Cox,, J. R. Perfect,, and J. Heitman. 2001. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol. Cell. Biol. 21:31793191.
25. Edberg, S. C.,, S.J. Chaskes,, E. Alture-Werber,, and J. M. Singer. 1980. Esculin-based medium for isolation and identification of Cryptococcus neoformans. J. Clin. Microbiol. 12:332335.
26. Eisenman, H. C.,, J. D. Nosanchuk,, J. B. Webber,, R. J. Emerson,, T. A. Camesano,, and A. Casadevall. 2005. Microstructure of cell wall-associated melanin in the human pathogenic fungus Cryptococcus neoformans. Biochemistry 44:36833693.
27. Enochs, W. S.,, T. Sarna, L. Zecca,, P.A. Riley,, and H. M. Swartz. 1994. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson’s disease: a hypothesis. J. Neural Transm. Park. Dis. Dement. Sect. 7:83100.
28. Erickson, T., L. Liu,, A. Gueyikian, X. Zhu,, J. Gibbons,, and P. R. Williamson. 2001. Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1. Mol. Microbiol. 42:11211131.
29. Feldmesser, M., Y. Kress, and, A. Casadevall. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:23552365.
30. Feldmesser, M.,, Y. Kress,, A. Mednick,, and A. Casadevall. 2000. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. J. Infect. Dis. 182:17911795.
31. Franzot, S. P.,, J. Mukherjee,, R. Cherniak,, L. C. Chen,, J. S. Hamdan,, and A. Casadevall. 1998. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect. Immun. 66:8997.
32. Frases, S.,, A. Salazar,, E. Dadachova,, and A. Casadevall. 2007. Cryptococcus neoformans can utilize the bacterial melanin precursor homogentisic acid for fungal melanogenesis. Appl. Environ. Microbiol. 73:615621.
33. Gan, E. V., H. F. Haberman, and, I. A. Menon. 1976. Electron transfer properties of melanin. Arch. Biochem. Biophys. 173:666672.
34. Garcia-Rivera, J., and, A. Casadevall. 2001. Melanization of Cryptococcus neoformans reduces its susceptibility to the antimicrobial effects of silver nitrate. Med. Mycol. 39:353357.
35. Garcia-Rivera, J.,, S. C. Tucker,, M. Feldmesser, P. R. Williamson,, and A. Casadevall. 2005. Laccase expression in murine pulmonary Cryptococcus neoformans infection. Infect. Immun. 73:31243127.
36. Gomez, B. L., and, J. D. Nosanchuk. 2003. Melanin and fungi. Curr. Opin. Infect. Dis. 16:9196.
37. Henson, J. M., M. J. Butler, and, A. W. Day. 1999. The dark side of the mycelium: melanins of phytopathogenic fungi. Annu. Rev. Phytopathol. 37:447471.
38. Heung, L. J.,, A. E. Kaiser,, C. Luberto,, and M. Del Poeta. 2005. The role and mechanism of diacylglycerolprotein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. J. Biol. Chem. 280:2854728555.
39. Heung, L. J.,, C. Luberto,, A. Plowden,, Y. A. Hannun,, and M. Del Poeta. 2004. The sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans. J. Biol. Chem. 279:2114421153.
40. Hill, H. Z. 1991. Melanins in the photobiology of skin cancer and the radiobiology of melanomas, p. 3153. In S. H. Wilson (ed.), Cancer Biology and Biosynthesis. Telford Press, Caldwell, NJ.
41. Huffnagle, G. B.,, G.H. Chen,, J. L. Curtis, R. A. McDonald, R. M. Strieter,, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melaninproducing strain of Cryptococcus neoformans. J. Immunol. 155:35073516.
42. Idnurm, A.,, J. L. Reedy,, J.C. Nussbaum,, and J. Heitman. 2004. Cryptococcus neoformans virulence gene discovery through insertional mutagenesis. Eukaryot. Cell 3:420429.
43. Ikeda, R., and, E. S. Jacobson. 1992. Heterogeneity of phenol oxidases in Cryptococcus neoformans. Infect. Immun. 60:35523555.
44. Ikeda, R.,, T. Shinoda,, T. Morita, and, E. S. Jacobson. 1993. Characterization of a phenol oxidase from Cryptococcus neoformans var. neoformans. Microbiol. Immunol. 37:759764.
45. Ikeda, R.,, T. Sugita,, E.S. Jacobson,, and T. Shinoda. 2003. Effects of melanin upon susceptibility of Cryptococcus to antifungals. Microbiol. Immunol. 47:271277.
46. Ito, S. 1993. Biochemistry and physiology of melanin, pp. 3359. In N. Levine (ed.), Pigmentation and Pigmentary Disorders. CRC Press, Boca Raton, FL.
47. Ito, S., and, K. Fujita. 1985. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal. Biochem. 144:527536.
48. Jacobson, E. S., and, G. M. Compton. 1996. Discordant regulation of phenoloxidase and capsular polysaccharide in Cryptococcus neoformans. J. Med. Vet. Mycol. 34:289291.
49. Jacobson, E. S., and, H. S. Emery. 1991. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J. Bacteriol. 173:401403.
50. Jacobson, E. S., and, H. S. Emery. 1991. Temperature regulation of the cryptococcal phenoloxidase. J. Med. Vet. Mycol. 29:121124.
51. Jacobson, E. S., A. P. Goodner, and, K. J. Nyhus. 1998. Ferrous iron uptake in Cryptococcus neoformans. Infect. Immun. 66:41694175.
52. Jacobson, E. S., and, J. D. Hong. 1997. Redox buffering by melanin and Fe(II) in Cryptococcus neoformans. J. Bacteriol. 179:53405346.
53. Jacobson, E. S., and, R. Ikeda. 2005. Effect of melanization upon porosity of the cryptococcal cell wall. Med. Mycol. 43:327333.
54. Jacobson, E. S., N. D. Jenkins, and, J. M. Todd. 1994. Relationship between superoxide dismutase and melanin in a pathogenic fungus. Infect. Immun. 62:40854086.
55. Jacobson, E. S., and, M. J. Petro. 1987. Extracellular iron chelation in Cryptococcus neoformans. J. Med. Vet. Mycol. 25:415418.
56. Jacobson, E. S., and, S. B. Tinnell. 1993. Antioxidant function of fungal melanin. J. Bacteriol. 175:71027104.
57. Jung, W. H., and, J. W. Kronstad. 2008. Iron and fungal pathogenesis: a case study with Cryptococcus neoformans. Cell. Microbiol. 10:277284.
58. Jung, W. H.,, A. Sham,, R. White, and, J. W. Kronstad. 2006. Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol. 4: e410.
59. Kaliszan, R., A. Kaliszan, and, I. W. Wainer. 1993. Prediction of drug binding to melanin using a melaninbased high-performance liquid chromatographic stationary phase and chemometric analysis of the chromatographic data. J. Chromatogr. 615:281288.
60. Kaya, M.,, D. P Edward,, H. Tessler, and, R. L. Hendricks. 1992. Augmentation of intraoccular inflammation by melanin. Invest. Ophthamol. Vis. Sci. 33:522531.
61. Kojima, Y.,, Y. Tsukuda,, Y. Kawai,, A. Tsukamoto,, J. Sugiura,, M. Sakaino,, and Y. Kita. 1990. Cloning, sequence analysis, and expression of ligninolytic phenoloxidase genes of the whiterot basidiomycete Coriolus hirsutus. J. Biol. Chem. 265:1522415230.
62. Korth, H., and, G. Pulverer. 1971. Pigment formation for differentiating Cryptococcus neoformans from Candida albicans. Appl. Microbiol. 21:541542.
63. Kuo, M. J., and, M. Alexander. 1967. Inhibition of the lysis of fungi by melanins. J. Bacteriol. 94:624629.
64. Kwon-Chung, K. J., I. Polacheck, and, T. J. Popkin. 1982. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J. Bacteriol. 150:14141421.
65. Kwon-Chung, K. J., and, J. C. Rhodes. 1986. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:218223.
66. Kwon-Chung, K. J., W. K. Tom, and, J. L. Costa. 1983. Utilization of indole compounds by Cryptococcus neoformans to produce a melanin-like pigment. J. Clin. Microbiol. 18:14191421.
67. Lamy-Freund, M. T.,, S. Schreier,, R. M. Peitzsch, and, W. F. Reed. 1991. Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering. J. Pharm. Sci. 80:262266.
68. Langhof, H., M. Feuerstein, and, G. Schabinski. 1965. Melaninantikorperbildung bei Vitiligo. Hautarzt 16:209212.
69. Larsson, B. S. 1993. Interaction between chemicals and melanin. Pigment Cell Res. 6:127133.
70. Lazera, M. S.,, F. D. Pires,, L. Camillo-Coura,, M. M. Nishikawa,, C. C. Bezerra,, L. Trilles,, and B. Wanke. 1996. Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J. Med. Vet. Mycol. 34:127131.
71. Lee, S. C.,, D.W. Dickson, and, A. Casadevall. 1996. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenic implications. Hum. Pathol. 27:839847.
72. Liu, L., R. P. Tewari, and, P. R. Williamson. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:60346039.
73. Liu, O. W.,, C.D. Chun,, E.D. Chow,, C. Chen,, H. D. Madhani,, and S. M. Noble. 2008. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135:174188.
74. Luther, J. P., and, H. Lipke. 1980. Degradation of melanin by Aspergillus fumigatus. Appl. Environ. Microbiol. 40:145155.
75. Mandal, P.,, U. Banerjee,, A. Casadevall, and, J. D. Nosanchuk. 2005. Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India. J. Clin. Microbiol. 43:47664772.
76. Martinez, L. R., and, A. Casadevall. 2006. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 50:10211033.
77. McClelland, E. E.,, P. Bernhardt, and, A. Casadevall. 2006. Estimating the relative contributions of virulence factors for pathogenic microbes. Infect. Immun. 74:15001504.
78. Mednick, A. J.,, J.D. Nosanchuk, and, A. Casadevall. 2005. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect. Immun. 73:20122019.
79. Mironenko, N. V.,, I.A. Alekhina,, N.N. Zhdanova,, and S. A. Bulat. 2000. Intraspecific variation in gammaradiation resistance and genomic structure in the filamentous fungus Alternaria alternata: a case study of strains inhabiting Chernobyl reactor no. 4. Ecotoxicol. Environ. Safety 45:177187.
80. Missall, T. A.,, J.M. Moran,, J.A. Corbett,, and J. K. Lodge. 2005. Distinct stress responses of two functional laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant Tsa1. Eukaryot. Cell 4:202208.
81. Mohagheghpour, N.,, N. Waleh,, S. J. Garger,, L. Dousman,, L. K. Grill,, and D. Tuse. 2000. Synthetic melanin suppresses production of proinflammatory cytokines. Cell. Immunol. 199:2536.
82. Mylonakis, E.,, F.M. Ausubel,, J.R. Perfect,, J. Heitman,, and S. B. Calderwood. 2002. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl. Acad. Sci. USA 99:1567515680.
83. Neilson, J. B., M. H. Ivey, and, G. S. Bulmer. 1978. Cryptococcus neoformans: pseudohyphal forms surviving culture with Acanthamoeba polyphaga. Infect. Immun. 20:262266.
84. Nielsen, K.,, A. L. De Obaldia, and, J. Heitman. 2007. Cryptococcus neoformans mates on pigeon guano: implications for the realized ecological niche and globalization. Eukaryot. Cell 6:949959.
85. Nosanchuk, J., and, A. Casadevall. 1997. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect. Immun. 65:18361841.
86. Nosanchuk, J. D., and, A. Casadevall. 2003. Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa. Microbiology 149:19451951.
87. Nosanchuk, J. D., and, A. Casadevall. 2006. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob. Agents Chemother. 50:35193528.
88. Nosanchuk, J. D.,, R. Ovalle, and, A. Casadevall. 2001. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. J. Infect. Dis. 183:10931099.
89. Nosanchuk, J. D.,, A.L. Rosas, and, A. Casadevall. 1998. The antibody response to fungal melanin in mice. J. Immunol. 160:60266031.
90. Nosanchuk, J. D.,, A. L. Rosas,, S. C. Lee,, and A. Casadevall. 2000. Melanisation of Cryptococcus neoformans in human brain tissue. Lancet 355:20492050.
91. Nosanchuk, J. D.,, P. Valadon,, M. Feldmesser,, and A. Casadevall. 1999. Melanization of Cryptococcus neoformans in murine infection. Mol. Cell. Biol. 19:745750.
92. Noverr, M. C.,, P.R. Williamson,, R.S. Fajardo,, and G. B. Huffnagle. 2004. CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect. Immun. 72:16931699.
93. Nurudeen, T. A., and, D. G. Ahearn. 1979. Regulation of melanin production by Cryptococcus neoformans. J. Clin. Microbiol. 10:724729.
94. Nyhus, K. J., A. T. Wilborn, and, E. S. Jacobson. 1997. Ferric iron reduction by Cryptococcus neoformans. Infect. Immun. 65:434438.
95. Perfect, J. R.,, K.A. Marr,, T. J. Walsh,, R. N. Greenberg,, B. DuPont,, J. de la Torre-Cisneros,, G. Just-Nubling,, H. T. Schlamm,, I. Lutsar,, A. Espinel-Ingroff,, and E. Johnson. 2003. Voriconazole treatment for lesscommon, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:11221131.
96. Pierini, L. M., and, T. L. Doering. 2001. Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol. Microbiol. 41:105115.
97. Polacheck, I., V. J. Hearing, and, K. J. Kwon-Chung. 1982. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J. Bacteriol. 150:12121220.
98. Polacheck, I., and, K. J. Kwon-Chung. 1988. Melanogenesis in Cryptococcus neoformans. J. Gen. Microbiol. 134:10341041.
99. Polacheck, I., Y. Platt, and, J. Aronovitch. 1990. Catecholamines and virulence of Cryptococcus neoformans. Infect. Immun. 58:29192922.
100. Pukkila-Worley, R.,, Q.D. Gerrald,, P.R. Kraus,, M.J. Boily,, M. J Davis,, S. S. Giles,, G. M Cox,, J. Heitman,, and J. A. Alspaugh. 2005. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot. Cell 4:190201.
101. Rhodes, J. C., and, K. J. Kwon-Chung. 1985. Production and regeneration of protoplasts from Cryptococcus. Sabouraudia 23:7780.
102. Rhodes, J. C., I. Polacheck, and, K. J. Kwon-Chung. 1982. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect. Immun. 36:11751184.
103. Riley, P. A. 1991. Melanogenesis: a realistic target for antimelanoma therapy? Eur. J. Cancer 27:11721177.
104. Rosas, A. L., and, A. Casadevall. 1997. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. FEMS Microbiol. Lett. 153:265272.
105. Rosas, A. L., and, A. Casadevall. 2001. Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation. Mycopathologia 151:5356.
106. Rosas, A. L.,, R. S. MacGill,, J. D. Nosanchuk,, T. R. Kozel,, and A. Casadevall. 2002. Activation of the alternative complement pathway by fungal melanins. Clin. Diagn. Lab. Immunol. 9:144148.
107. Rosas, A. L.,, J.D. Nosanchuk, and, A. Casadevall. 2001. Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect. Immun. 69:34103412.
108. Rosas, A. L.,, J. D. Nosanchuk,, M. Feldmesser,, G. M. Cox,, H. C. McDade,, and A. Casadevall. 2000. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect. Immun. 68:28452853.
109. Ruiz, A., R. A. Fromtling, and, G. S. Bulmer. 1981. Distribution of Cryptococcus neoformans in a natural site. Infect. Immun. 31:560563.
110. Ruiz, A., J. B. Neilson, and, G. S. Bulmer. 1982. Control of Cryptococcus neoformans in nature by biotic factors. Sabouraudia 20:2129.
111. Salas, S. D.,, J.E. Bennett,, K. J. Kwon-Chung, J. R. Perfect,, and P. R. Williamson. 1996. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184:377386.
112. Shaw, C. E., and, L. Kapica. 1972. Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans. Appl. Microbiol. 24:824830.
113. Sichel, G.,, C. Corsaro,, M. Scalia,, A. J. Di Bilio, and, R. P. Bonomo. 1991. In vitro scavenger activity of some flavonoids and melanins against O2-(.). Free Radic. Biol. Med. 11:18.
114. Sinilova, N. G.,, Z.G. Pershina,, A.P. Duplitseva,, and I. B. Pavlova. 1969. A radio-resistant pigmented bacterial culture isolated from atomic reactor water. Zh. Mikrobiol. Epidemiol. Immunobiol. 46:9499. (In Russian.)
115. Staib, F. 1962. Cryptococcus neoformans and Guizotia abyssicnica (syn. G. Oleifera D.C.). Z. Hyg. 148:466475.
116. Steenbergen, J. N.,, H.A. Shuman, and, A. Casadevall. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. USA 98:1524515250.
117. Stoetzner, H., and, C. Kemmer. 1971. The morphology of Cryptococcus neoformans in human cryptococcosis. A light-, phase-contrast and electron-microscopic study. Mycopathol. Mycol. Appl. 45:327335.
118. Strachan, A. A.,, R.J. Yu, and, F. Blank. 1971. Pigment production of Cryptococcus neoformans grown with extracts of Guizotia abyssinica. Appl. Microbiol. 22:478479.
119. Tangen, K. L.,, W.H. Jung,, A. P. Sham, T. Lian,, and J. W. Kronstad. 2007. The iron- and cAMP-regulated gene SIT1 influences ferrioxamine B utilization, melanization and cell wall structure in Cryptococcus neoformans. Microbiology 153:2941.
120. Tian, S.,, J. Garcia-Rivera,, B. Yan,, A. Casadevall, and, R. E. Stark. 2003. Unlocking the molecular structure of fungal melanin using 13C biosynthetic labeling and solidstate NMR. Biochemistry 42:81058109.
121. Torres-Guererro, H., and, J. C. Edman. 1994. Melanindeficient mutants of Cryptococcus neoformans. J. Med. Vet. Mycol. 32:303313.
122. Valentine, J. S., and, E. B. Gralla. 1997. Delivering copper inside yeast and human cells. Science 278:817818.
123. Van Duin, D., A. Casadevall, and, J. D. Nosanchuk. 2002. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibility to amphotericin B and caspofungin. Antimicrob. Agents Chemother. 46:33943400.
124. Van Duin, D.,, W. Cleare,, O. Zaragoza,, A. Casadevall, and, J. D. Nosanchuk. 2004. Effects of voriconazole on Cryptococcus neoformans. Antimicrob. Agents Chemother. 48:20142020.
125. Wakamatsu, K., and, S. Ito. 2002. Advanced chemical methods in melanin determination. Pigment Cell Res. 15:174183.
126. Walton, F. J.,, A. Idnurm, and, J. Heitman. 2005. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol. Microbiol. 57:13811396.
127. Wang, H. S., R. T. Zeimis, and, G. D. Roberts. 1977. Evaluation of a caffeic acidferric citrate test for rapid identification of Cryptococcus neoformans. J. Clin. Microbiol. 6:445449.
128. Wang, P.,, M. E. Cardenas,, G. M. Cox,, J. R. Perfect,, and J. Heitman. 2001. Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans. EMBO Rep. 2:511518.
129. Wang, Y., P. Aisen, and, A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:31313136.
130. Wang, Y., P. Aisen, and, A. Casadevall. 1996. Melanin, melanin “ghosts,” and melanin composition in Cryptococcus neoformans. Infect. Immun. 64:24202424.
131. Wang, Y., and, A. Casadevall. 1994. Decreased susceptibility of melanized Cryptococus neoformans to UV light. Appl. Environ. Microbiol. 60:38643866.
132. Wang, Y., and, A. Casadevall. 1994. Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother. 38:26482650.
133. Wang, Y., and, A. Casadevall. 1994. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect. Immun. 62:30043007.
134. Wang, Y., and, A. Casadevall. 1996. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine. Antimicrob. Agents Chemother. 40:541545.
135. Wassermann, H. P., and, J. J. Van Der Walt. 1973. Antibodies against melanin: the significance of negative results. S. Afr. Med. J. 47:79.
136. Wheeler, M. H., and, A. A. Bell. 1988. Melanins and their importance in pathogenic fungi. Curr. Top. Med. Mycol. 2:338387.
137. Williamson, P. R. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176:656664.
138. Williamson, P. R. 1997. Laccase and melanin in the pathogenesis of Cryptococcus neoformans. Front. Biosci. 2: e99–e107.
139. Yang, Z.,, R. C Pascon,, A. Alspaugh,, G. M. Cox, and, J. H. McCusker. 2002. Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant. Microbiology 148:26172625.
140. Youdim, M. B.,, D. Ben-Sachar, and, P. Riederer. 1994. The enigma of neuromelanin in Parkinson’s disease substantia nigra. J. Neural Transm. Suppl. 43:113122.
141. Zhang, S., A. Varma, and, P. R. Williamson. 1999. The yeast Cryptococcus neoformans uses ‘mammalian’ enhancer sites in the regulation of the virulence gene, CNLAC1. Gene 227:231240.
142. Zhu, X.,, J. Gibbons,, J. Garcia-Rivera,, A. Casadevall, and, P. R. Williamson. 2001. Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect. Immun. 69:55895596.
143. Zhu, X.,, J. Gibbons,, S. Zhang, and, P. R. Williamson. 2003. Copper-mediated reversal of defective laccase in a Deltavph1 avirulent mutant of Cryptococcus neoformans. Mol. Microbiol. 47:10071014.
144. Zhu, X., and, P. R. Williamson. 2004. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res. 5:110.
145. Zuger, A., E. Louie,, R.S. Holzman,, M.S. Simberkoff,, and J. J. Rahal. 1986. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann. Intern. Med. 104:234240.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error